Neubase Therapeutics Inc. buy fchar99
Start price
14.07.17
/
50%
€248.59
Target price
01.12.17
€432.96
Performance (%)
74.17%
End price
01.12.17
€432.96
Summary
This prediction ended on 01.12.17 with a price of €432.96. The BUY prediction by fchar99 for Neubase Therapeutics Inc. saw massive gains of 74.17%. fchar99 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neubase Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by fchar99 for this prediction
In the thread NeuBase Therapeutics Inc. diskutieren
fchar99 stimmt dem Sentiment von 'Buy' zu
fchar99 stimmt am 14.07.2017 dem Buy-Gesamtsentiment mit dem Kursziel 4.2$ zu.
(Zielkurs erreicht)

